What is the efficacy of adjuvant radioiodine therapy for papillary thyroid carcinoma (PTC)?

Updated: Jun 18, 2020
  • Author: Ponnandai S Somasundar, MD, MPH, FACS; Chief Editor: Neetu Radhakrishnan, MD  more...
  • Print
Answer

Some patients have elevated stimulated thyroglobulin concentrations after reoperation for recurrent or persistent papillary thyroid cancer. Yim and colleagues found that in such patients, adjuvant radioiodine therapy resulted in no significant differences compared with no additional radioiodine therapy. [54]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!